DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Gill S, Ko YJ, Cripps C. et al.
PANCREOX: a randomized phase III study of 5-fluorouracil/leucovorin with or without oxaliplatin for second-line advanced pancreatic cancer in patients who have received gemcitabine-based chemotherapy.
J Clin Oncol 2016;
34: 3914-3920
We do not assume any responsibility for the contents of the web pages of other providers.